Skip to content
10-Q

Quarterly Report

U S PHYSICAL THERAPY INC /NV USPH

0001140361-25-041152

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 15.2M sh
Shares Diluted Q3 2025 · Sep 30, 2025 15.2M sh
Shares Diluted Q3 2025 · Sep 30, 2025 15.18M sh
Shares Diluted Q3 2025 · Sep 30, 2024 15.08M sh
Shares Diluted Q3 2025 · Sep 30, 2024 15.06M sh
Dividends Paid Q3 2025 · Sep 30, 2025 $20.52M
Dividends Paid Q3 2025 · Sep 30, 2024 $19.9M
Capex Q3 2025 · Sep 30, 2025 $10.15M
Capex Q3 2025 · Sep 30, 2024 $6.7M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $50.13M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $55.53M
Long Term Debt Q3 2025 · Sep 30, 2025 $151.46M
Long Term Debt Q3 2025 · Dec 31, 2024 $142.53M
Short Term Debt Q3 2025 · Sep 30, 2025 $8.8M
Short Term Debt Q3 2025 · Dec 31, 2024 $11M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $31.1M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $41.36M
Stockholders Equity Q3 2025 · Sep 30, 2025 $503.57M
Stockholders Equity Q3 2025 · Dec 31, 2024 $488.93M
Current Liabilities Q3 2025 · Sep 30, 2025 $115.08M
Current Liabilities Q3 2025 · Dec 31, 2024 $116.28M
Total Liabilities Q3 2025 · Sep 30, 2025 $413.83M
Total Liabilities Q3 2025 · Dec 31, 2024 $408.42M
Current Assets Q3 2025 · Sep 30, 2025 $138.44M
Current Assets Q3 2025 · Dec 31, 2024 $137.58M
Total Assets Q3 2025 · Sep 30, 2025 $1.2B
Total Assets Q3 2025 · Dec 31, 2024 $1.17B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.48
Eps Diluted Q3 2025 · Sep 30, 2025 $1.85
Eps Diluted Q3 2025 · Sep 30, 2024 $0.39
Eps Diluted Q3 2025 · Sep 30, 2024 $1.32
Eps Basic Q3 2025 · Sep 30, 2025 $0.48
Eps Basic Q3 2025 · Sep 30, 2025 $1.85
Eps Basic Q3 2025 · Sep 30, 2024 $0.39
Eps Basic Q3 2025 · Sep 30, 2024 $1.32
Sga Expense Q3 2025 · Sep 30, 2025 $17.41M
Sga Expense Q3 2025 · Sep 30, 2025 $51.14M
Sga Expense Q3 2025 · Sep 30, 2024 $14.39M
Sga Expense Q3 2025 · Sep 30, 2024 $42.72M
Net Income Q3 2025 · Sep 30, 2025 $13.14M
Net Income Q3 2025 · Sep 30, 2025 $35.43M
Net Income Q3 2025 · Sep 30, 2024 $6.63M
Net Income Q3 2025 · Sep 30, 2024 $22.18M
Operating Income Q3 2025 · Sep 30, 2025 $25.33M
Operating Income Q3 2025 · Sep 30, 2025 $69.91M
Operating Income restated Q3 2025 · Sep 30, 2024 $12.85M
Operating Income restated Q3 2025 · Sep 30, 2024 $43.34M
Gross Profit Q3 2025 · Sep 30, 2025 $36.87M
Gross Profit Q3 2025 · Sep 30, 2025 $109.56M
Gross Profit Q3 2025 · Sep 30, 2024 $29.13M
Gross Profit Q3 2025 · Sep 30, 2024 $91.39M
Revenue Q3 2025 · Sep 30, 2025 $197.13M
Revenue Q3 2025 · Sep 30, 2025 $578.26M
Revenue Q3 2025 · Sep 30, 2024 $168.03M
Revenue Q3 2025 · Sep 30, 2024 $490.9M